These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8791975)

  • 1. Sucralfate gel versus placebo in patients with non-erosive gastro-oesophageal reflux disease.
    Simon B; Ravelli GP; Goffin H
    Aliment Pharmacol Ther; 1996 Jun; 10(3):441-6. PubMed ID: 8791975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease. Rabeprazole Study Group.
    Birbara C; Breiter J; Perdomo C; Hahne W
    Eur J Gastroenterol Hepatol; 2000 Aug; 12(8):889-97. PubMed ID: 10958216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucralfate versus placebo in treatment of non-ulcer dyspepsia.
    Kairaluoma MI; Hentilae R; Alavaikko M; Kellosalo J; Stahlberg M; Jalovaara P; Olsen M; Jaervensivu P; Laitinen S
    Am J Med; 1987 Sep; 83(3B):51-5. PubMed ID: 3310629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
    Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
    Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease.
    Johnsson F; Weywadt L; Solhaug JH; Hernqvist H; Bengtsson L
    Scand J Gastroenterol; 1998 Jan; 33(1):15-20. PubMed ID: 9489902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oesophageal reflux disease. Diagnosis, pathophysiology and treatment with special reference to the role of sucralfate.
    Elsborg L
    Scand J Gastroenterol Suppl; 1987; 127():101-9. PubMed ID: 3475767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease.
    Netzer P; Schmitt B; Inauen W
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1481-90. PubMed ID: 12182748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study.
    Gudjónsson H; Oddsson E; Björnsson S; Gunnlaugsson O; Theodors A; Jónasson TA; Bonnevie O; Thjodleifsson B
    Scand J Gastroenterol; 1993 Nov; 28(11):969-72. PubMed ID: 8284632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial.
    Shaheen NJ; Denison H; Björck K; Karlsson M; Silberg DG
    Gut; 2013 Sep; 62(9):1248-55. PubMed ID: 22730470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water load test before and after PPI therapy in patients with gastro-oesophageal reflux disease.
    Battaglia E; Grassini M; Navino M; Niola P; Verna C; Mazzocchi A; Clerici C; Morelli A; Bassotti G
    Dig Liver Dis; 2007 Dec; 39(12):1052-6. PubMed ID: 17913607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux.
    Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF
    Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review.
    Gallusi G; Pontone S
    Arab J Gastroenterol; 2018 Jun; 19(2):51-55. PubMed ID: 29935866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
    Vakil N; Talley NJ; Stolte M; Sundin M; Junghard O; Bolling-Sternevald E
    Aliment Pharmacol Ther; 2006 Jul; 24(1):55-63. PubMed ID: 16803603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis.
    Williams RM; Orlando RC; Bozymski EM; Readling RD; Castell DO; Roufail WM; Rick GG; Rubin SE; Sinar DR
    Am J Med; 1987 Sep; 83(3B):61-6. PubMed ID: 3310630
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.